Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Currently Acting VP of Quality for SOHM building new facility and technology development.
International auditor, audited manufacturing operations and records at Sun Pharmaceuticals in India Faciliity in Halol as part of 483 remediation project.
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
"Sun Pharma is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over US $5 billion. Supported by more than 38,000 employees globally and 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Over the last two decades, Sun Pharma has established itself as a leading player in the generics market in the U.S. We are the 8th largest generics pharmaceutical company in the U.S. and are ranked 2nd by prescriptions in the U.S. dermatology market. We are rapidly ramping up our presence in the specialty branded market, with dermatology, ophthalmology and oncology as key target segments. Our U.S. business makes up 30% of our global revenue."
https://sunpharma.com/usa/
483 Remediation Project:
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-references/fda-form-483-frequently-asked-questions
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sun-pharmaceutical-industries-ltd-636199-12152022
_
imo, Rushing knows what he's doing. hL shmn
No argument from me. I've said as much too. Passing along the info.
hL
Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development
https://www.biomedwire.com/leadership-changes-at-sohm-inc-shmn-to-strengthen-growth-strategies-for-generic-drug-market-and-gene-editing-platform-development/
$SHMN to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development https://t.co/r4DlMvS812 pic.twitter.com/g4ls8nzlKy
— TraderPower (@TraderPower) September 14, 2023
$SHMN to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development https://t.co/PlDsZMmSB9 pic.twitter.com/tRyzLlqbEB
— SocialMediaRelations (@SMRelations) September 14, 2023
$SHMN to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development https://t.co/L5aNBeGF5k pic.twitter.com/NqpQbNbQd1
— IBN (InvestorBrandNetwork) (@IBNMediaNetwork) September 14, 2023
$SHMN to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development https://t.co/KP7AjBiYC9 pic.twitter.com/oBSkrMh91B
— BioMedWire (@BioMedWire) September 14, 2023
Sorry you're right, I just glanced at OTCM and I think it's delayed.
Even crazier, 4.9M MC.
https://www.otcmarkets.com/stock/HIRU/security
Thanks JM.
No shortage of big red shoes. That "insider" may have popped in here a couple times too, with information that made me go hmmm. Also have a feeling that several "longs" have been unloading lately. I'm not in deep, never really was but was waiting. ...but -30% today is disappointing. A Reversal can happen just as quick I know, depending on communications.
7M market cap.
Bourbon n' Coke.
hL
This one: https://x.com/Hirucorpnew/status/1641242876452687872?s=20
She used several commas. :)
I can see her with both thumbs a blazin.' :)
I have troubles, and I'm on a giant keyboard, with spellcheck.
hL
I think in times past some have attempted to get her to acknowledge her Tweeting style.
Reminds me a little of a texting teenager. Many adults do that, it's a little ADD is how I describe it. Attention deficit. No punctuation, disjointed.
It could also be James who's Tweeting, or the other guy, not sure.
However, her PR's are more articulate, imo.
Regardless, it leaves us to decipher sometimes. She's either burning the candle at both ends with all these irons in the fire, dealing with jet-lag, or maybe she was just eating chips and gauc, and sipping a margarita. :)
hL
"working on what territories we are going to cover"
Don't know what it means, but sounds interesting.
A lot of questions being asked, Alkaline 88 having some issues and trying to lock up business for sure and working on what territories we are going to cover and exploring the distilled water market, and other new customers. $HIRU
— @Hirucorp (@Hirucorpnew) September 12, 2023
August 16, 2023 WTER "Significant Strides Toward Profitability"
The Alkaline Water Company Reports Record Revenue of $63.8 Million in Fiscal Year 2023, Posts 16% Growth and Makes Significant Strides Toward Profitability
JM, I know you've read this PR, and even posted it here, but anyone reading this has to get the feeling that WTER isn't going anywhere soon, imo.
https://ir.thealkalinewaterco.com/news-events/press-releases/detail/479/the-alkaline-water-company-reports-record-revenue-of-63-8
"The Company reported historic high revenues of $63.8 Million, representing year-over-year growth of 16%. The Company also highlighted substantial progress on its Pathway to Profitability."
https://t.co/Non2XFj2E6. Our customer growing and HIRU growing with them. $HIRU
— @Hirucorp (@Hirucorpnew) August 16, 2023
I agree. Also looking at today's filing and the Directors compensation packages, I don't think those guys plan to go anywhere soon without a fight to maintain the foundation already laid. (As you commented on earlier, market penetration) Sure, better companies have gone by the wayside than WTER...but just as many examples can be given of Companies in similar circumstances that plowed thru to success. A88 has a niche with value, imo.
I'm not comparing WTER to any Fortune 500 Company, but lots of them were once counted out, and muscled through.
https://www.inc.com/drew-hendricks/5-successful-companies-that-didn-8217-t-make-a-dollar-for-5-years.html
Wondering if anyone has seen empty shelves of A88 in our coverage zone? Southwest and West. So far I've only seen pics from Florida.
Makes me wonder if our Zone is affected as much by this supply chain issue, or is it other zones. I have to believe we're at least moderately affected by the freight situation, maybe the timely delivery of A88 large bottles? Even more important reason to get that blow molder on premises, imo. Seems likely too that retail prices on A88 may have to increase for a bit to align with shipping costs, heck that's what all the other food items have done.
hL
Here's a working link to the 8K from the bottom of my previous post.
"The Letter further stated that the Company has until September 18, 2023 to submit a plan (the "Plan") to regain compliance with respect to the delinquent reports. The Letter also stated that any staff exemption to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or January 10, 2024."
https://www.otcmarkets.com/filing/html?id=16901336&guid=3Bg-kpu8ZQRnJth
__hL
WTER Still needs to file 1Q ending 3.31.23. Also today have filed for AS raise, to be voted on in upcoming SH meeting. Last year it was held on 9.27.22. A date isn't given here, but WTER seeks to raise AS from 13,333,333 to 100,000,000.
https://www.otcmarkets.com/filing/html?id=16927150&guid=3Bg-kpu8ZQRnJth
https://www.otcmarkets.com/stock/WTER/disclosure
"Purpose and Effect of the Increase in the Number of Authorized Shares of Our Common Stock
Our board of directors believes that an increase in the number of authorized shares of our common stock will provide us with the flexibility to meet business needs as they arise, to take advantage of favorable opportunities and to respond to a changing corporate environment. The increased reserve of shares available for issuance would give us the flexibility of using our common stock to raise capital and/or as consideration in acquiring other businesses.
The increased reserve of shares available for issuance may also be used to facilitate public or private financings. If sufficient operating funds cannot be generated by operations, we may need to, among other things, issue and sell our common stock, or securities convertible into our common stock, in private transactions. Such transactions might not be available on terms favorable to us, or at all. We may sell our common stock at prices less than the public trading price of our common stock at the time, and we may grant additional contractual rights to purchase our common stock not available to other holders of our common stock, such as warrants to purchase additional shares of our common stock or anti-dilution protections.
In addition, the increased reserve of shares available for issuance may be used for our equity incentive plan for grants to our directors, officers, employees and consultants, and those of our subsidiaries. Our board of directors believes that it is critical to incentivize our directors, officers, employees and consultants, and those of our subsidiaries through equity incentive awards. Such equity incentive plans may also be used to attract and retain employees or in connection with potential acquisitions if we grant options to the employees of the acquired companies. Our board of directors believes that our ability to achieve our growth strategy may be impaired without additional authorized shares of our common stock that could be used to provide such equity incentives.
The flexibility given to our board of directors to issue additional shares of our common stock could also have an anti-takeover effect and enhance our ability to negotiate on behalf of our stockholders in a takeover situation. The authorized but unissued shares of our common stock could be used by our board of directors to discourage, delay or make more difficult a change in the control of our company. For example, such shares could be privately placed with purchasers who might align themselves with our board of directors in opposing a hostile takeover bid. The issuance of additional shares could serve to dilute the stock ownership of persons seeking to obtain control and thereby increase the cost of acquiring a given percentage of the outstanding stock. Stockholders should therefore be aware that approval of this proposal could facilitate future efforts by our board of directors to deter or prevent changes in control of our company, including transactions in which our stockholders might otherwise receive a premium for their shares over then current market prices. The increase in our authorized capital stock, however, is not being proposed in response to any effort of which we are aware to accumulate shares of our common stock or to obtain control of our company.
The availability of additional shares of our common stock is particularly important in the event that our board of directors needs to undertake any of the foregoing actions on an expedited basis and therefore needs to avoid the time (and expense) of seeking stockholder approval in connection with the contemplated action. If this proposal is approved by our stockholders, our board of directors does not intend to solicit further stockholder approval prior to the issuance of any additional shares of our common stock, except as may be required by applicable laws or rules.
The possible future issuance of shares of equity securities consisting of our common stock or securities convertible into our common stock could affect our current stockholders in a number of ways, including the following:
- diluting the voting power of our current stockholders;
- diluting the market price of our common stock, to the extent that the shares of our common stock are issued and sold at prices below current trading prices of our common stock, or if the issuance consists of equity securities convertible into our common stock, to the extent that the securities provide for the conversion into our common stock at prices that could be below current trading prices of our common stock;
___
Watching them closely for the 1Q ending 3.31.23, and for any new filings related to petitioning Nasdaq for a 180 day extension.
https://www.otcmarkets.com/filing/html?id=16901336&guid=3Bg-
"The Letter further stated that the Company has until September 18, 2023 to submit a plan (the "Plan") to regain compliance with respect to the delinquent reports. The Letter also stated that any staff exemption to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or January 10, 2024."
__
hL
"Alkaline88 continues to have strong sales, and frankly our sales %, and unit % numbers YOY are outperforming most of our key competitors."
"We ask that you have patience as we resolve these supply chain issues and please rest assured we are taking all measures to correct these issues as soon as possible."
Impact regarding Yellow Freight:
"Yellow filed a so-called Chapter 11 petition in U.S. Bankruptcy Court in Delaware. The downfall of the 99-year-old company will lead to the loss of about 30,000 jobs and could have ripple effects across the nation's supply chains." Aug 7, 2023
https://www.nytimes.com/2023/08/07/business/yellow-trucking-bankruptcy.html#:~:text=Yellow%20filed%20a%20so%2Dcalled,across%20the%20nation's%20supply%20chains.
(Reuters) "Former customers of bankrupt trucking firm Yellow (YELL. O) can expect to see rates rise at least 10%-20% from the rock-bottom levels that helped usher in the demise of that nearly 100-year-old firm, industry analysts and executives said on Friday." Aug 11, 2023
https://www.reuters.com/business/autos-transportation/some-yellow-freight-customers-face-post-bankruptcy-sticker-shock-analysts-2023-08-11/#:~:text=Aug%2011%20(Reuters)%20%2D%20Former,and%20executives%20said%20on%20Friday.
https://www.wsj.com/articles/yellow-bankruptcy-us-economy-e2761b0b
https://www.nbcnews.com/business/consumer/yellow-trucking-bankruptcy-higher-shipping-costs-on-the-horizon-rcna98825
https://www.barrons.com/articles/trucking-bankruptcy-dented-august-jobs-growth-call-it-the-yellow-effect-d2583048
https://www.freightwaves.com/news/how-a-yellow-bankruptcy-would-uproot-supply-chains-in-real-time
---
The list above is very long, just Google it.
hL
Forgot to mention...if she is awarded new business in "private label snapcap gallon distilled water" with whomever...it might also open up (1) other opportunities with those retailers since she is filling an open demand.
(2)... a duplicate distilled water installation opportunity at the other plant.
hL
She has said there is "greater demand for distilled water," and "big box stores will be happy."
I can only assume she is certain that her investment in the equipment, plumbing, electrical, and labor (all significant) in order to reach 900 gallons per hour...will pay for itself many times over ...over time.
To be fair, the retail price per gallon of snap cap, one gallon distilled water...is low, which she knows. So she will need to run that equipment at near max capacity for 1-2 shifts per day, in order to generate approx 1.5M per year revenues. If my calculations are close, imo.
The way I look at it, that pays a year's salaries, lots of overhead, debt, however she wants to use it. Money we didn't have. Distilled water is in higher demand for various reasons, perhaps that will drive prices in time.
Contracts? Don't know.
Confidence it will bring ROI?
I'd say yes, imo.
Respects. hL
PS: The distilled water equipment really needs to dovetail with a new blow molder capable of blowing 1Ga snapcap bottles, imo.
Draw your own conclusions:
I was an investor up until 1 PM mountain time today when I dumped the rest of my shares. 35 36 37. It’s almost like I knew $hiru was going to try and shit all over my bag, again.
— Justin Case (@BlameCanada8) September 12, 2023
I got rid of 75% above $0.004 last week and dumped the rest at $0.0038. $WTER & the buy back suspension didn't smell right.
— Gin & Chronic (@BlowCokeUpMyAss) September 12, 2023
Very reasonable, and no argument from me for the most part. I've asked her for an update on what you mentioned, and anyone that has those questions can send her a message.
$hiru At this point, we're unsure of what % of our business is A88. Can you comment on how their challenges are anticipated to affect you this Qtr, or Annual 2023. Are we on target still for your revenue projection, moderate reduction, more than moderate? Maybe a PR w/updates?
— Dave (@hardlesson1) September 12, 2023
Buybacks overblown. Like I said before, her buying volume should be irrelevant, imo.
$25,000 per month bought at .004 is a whopping 6,250,000 shares per month.
Insignificant in the bucket of monthly volume.
But we do now have confirmation that they haven't been buying like they said, and why. That I'm sure won't make many happy. So the real issue here isn't the buybacks themselves...that only satisfies flippy...what we need is an update on operations and revenue adjustments if anticipated. I see JOL has asked them for specifics.
I always wonder about those who express sadistic glee if a company has a hiccup. It also tells you who who shares and who doesn't. So as far as tomorrow goes, I'm not sure it really matters in the long run. An update from the company would be nice, rather than the "fact" spewing uncurated prognosticators.
:)
hL. Hiru
Ps: thanks QT for the use of "uncurated."
$0 to $27,000,000 in 24 months that's just out of line:
:)
Remember when that happened?
Really that happened with an OTC stock?
Remember when flippy got hot about his 2 ticks? He/She keeps popping up to vent.
Remember when Denman got added to the fins finally?
She's not perfect, I've personally called her, and her accountant(s) out...one of them even messeged me.
Let's hold her accountable, not panic, look at the big Revenue picture, and move on.
Maybe future communications will improve sentiment, let's see.
hL
$27,648,765 Revenues since 9.30.21. Terrible. :)
She can't do anything right. :)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172589013
__
hL
$SHMN Names Seasoned Veteran as VP of Quality:
BioMedNewsBreaks – $SHMN Names Seasoned Veteran as VP of Quality https://t.co/caaVg9WXhj pic.twitter.com/FkHfFFETZd
— ActionPicks (@ActionStocks) September 12, 2023
BioMedNewsBreaks – $SHMN Names Seasoned Veteran as VP of Quality https://t.co/9DDlBQQwAA pic.twitter.com/DMK7fQoY2O
— NewsWireMedia (@NewsWireMedia1) September 12, 2023
BioMedNewsBreaks – $SHMN Names Seasoned Veteran as VP of Quality https://t.co/grIxYtnany pic.twitter.com/PBEw0vpVTP
— IBN (InvestorBrandNetwork) (@IBNMediaNetwork) September 12, 2023
"I'm going to buy 5 Million on the ASK next week."
Flippy: "oh good, I'll buy today, and she'll buy next week for 2 ticks."
(Next week comes and goes, and she didn't Tweet she bought.)
Flippy: "oh god, now I'm down two ticks, I'm selling." (Runs out of room hair on fire.)
___
The whole thing is ridiculous, imo. Yes, she needs to buy $25,000 per month, like she said she would...but I could care less about flippy getting his two ticks. hL
I agree. People say she's not buying, but who knows. I don't have a crystal ball like they do I guess. What would be a shame is if she has been buying a bunch, and flippy thought she wasn't so they sold in panic. Fact is, her monthly volume shouldn't matter. I think it's more related to silence, the WTER filing being late, unknowns, and fickle OTC traders running to play something else.
You got me, but things can turn on a dime (up or down) with an update, imo. hL
(Edit) Translation: "Boo Hoo, the CEO won't buy my flip shares."
"But she said she was going to start buying, so I loaded some more flip shares to sell to her, but then I had to take a loss on my flip shares. I don't like her, nothing she says can be believed because she didn't buy my flip shares like she did on the last run ups."
Poor flippy.
hL
What it means when a CEO "certifies" Financial Statements:
Take a minute:
I, Kathryn Gavin certify that:
1. I have reviewed this Quarterly Disclosure Statement (2
nd Quarter ended June 30, 2023) for HIRU Corp.;
2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and
3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement.
August 3, 2023
/s/ Kathryn Gavin
Chief Financial Officer
https://www.otcmarkets.com/otcapi/company/financial-report/377930/content
CERTIFY...mean(s) to testify to the truth or genuineness of something.
CERTIFY usually applies to a written statement, especially one carrying a signature or seal.
https://www.merriam-webster.com/dictionary/certify#:~:text=certify%2C%20attest%2C%20witness%2C%20vouch,carrying%20a%20signature%20or%20seal.
"The Sarbanes-Oxley Act of 2002 requires the CEO and CFO of publicly traded companies to issue a statement certifying that the accompanying financial statements and disclosures fairly present, in all material respects, the operations and financial condition of the company."
http://archives.cpajournal.com/2003/0703/features/f073603.htm#:~:text=The%20Sarbanes%2DOxley%20Act%20of%202002%20requires%20the%20CEO%20and,financial%20condition%20of%20the%20company.
But, what if they don't tell the truth?
"Implications for CEOs and CFOs. The CEO and CFO could face significant penalties if they certify that the company’s books are accurate when they are not. The executives could face up to a five-year prison sentence, fines, and other disciplinary action such as civil and criminal litigation, as well as being barred by the SEC from ever serving as a corporate officer or director. Perhaps this “legal” responsibility, the basic premise that any wrongdoing will not go unpunished, will raise the stakes for those who would mislead investors and the public.
Consequently, now that executives are being held personally responsible for their companies’ financial statements, they must worry more than ever about their personal bottom lines..."
The certifications will certainly require more due diligence for the CEO, the CFO, the audit committees, internal auditors, and the auditors in reviewing the financial statements and the underlying process in preparing the statements as well as at all other levels of financial management. And in the event of another failure like WorldCom or Enron, the certification by the CEO and CFO is unlikely to protect the auditors, the audit committee, and other senior accountants from legal liability. Until the first case is tried under the Sarbanes-Oxley Act, however, the full extent of this liability will remain unknown.
Putting Teeth into the Bite?
During his term as SEC Chairman, Harvey Pitt was quoted in the New York Times as saying, “[W]e are determined to give real teeth and meaning to the protections of the new law.” Conventional wisdom suggests that when people know they can and will be held accountable for their actions, their behaviors change. In these cases, therefore, the new rule should make it easier for government officials to make fraud cases against executives found to have intentionally filed false certifications under perjury charges. Roel C. Campos, a Texas businessman and former federal prosecutor before becoming an SEC Commissioner, described the new certification requirements simply. “What is being required,” he told the New York Times, “is that senior executive officials must say, ‘You have my word that what I am saying is accurate, and I realize if I fib, I will be in a heap of trouble.’”
http://archives.cpajournal.com/2003/0703/features/f073603.htm#:~:text=The%20Sarbanes%2DOxley%20Act%20of%202002%20requires%20the%20CEO%20and,financial%20condition%20of%20the%20company.
____
Read the full article, highlights above are mine, but you get the point.
While Kathryn hasn't been perfect on her filings, she has made changes to accountants, made some corrections, restated "lower" debt, etc. To my knowledge she has not corrected Topline Revenues, or Net profits.
So ask yourself, with what's at stake, would you "certify" the Disclosures and Financial statements if you knew they were incorrect?
imo. hL hiru
PS: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170865794
Rushing has put Sohm back on his LinkedIn profile:
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://twitter.com/Beeken_health/status/1701235463745380760?s=20
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-as-VP-of-Quality-with-Immediate-Effect?id=413696
__
hL shmn
9.11.23 News: https://www.globenewswire.com/news-release/2023/09/11/2740933/0/en/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-as-VP-of-Quality-with-Immediate-Effect.html
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
September 11, 2023 09:45 ET
| Source: SOHM, Inc.
CHINO HILLS, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of Wm. Dewey Rushing as a Vice President-Quality with the company.
Baron Night, SOHM president and CEO, said Mr. Rushing has been serving the company as an Advisory Board member since 2022 and, based on his experience in management and leadership, has decided to accept a role as a full-time VP-Quality.
Mr. Night stated: "Wm. Dewey Rushing is a senior compliance remediation and quality professional with more than 30 years of experience in quality assurance and cGMP compliance for FDA-regulated products. He joined SOHM’s Advisory Board last year and has been providing his expertise on validation and compliance issues. SOHM has appointed him as the Vice President of Quality, recognizing his exceptional qualifications and experience in pharmaceutical quality validation and cGMP compliance."
Mr. Rushing’s experience in cell therapy IND readiness, quality systems audits, aseptic processing, cGMP compliance and regulation, and process validation and transfer will be valuable assets for the company’s recent development. He holds a B.A. in biology and B.S. in microbiology from Kansas State University (1989), as well as a Master of Science in pharmaceutical regulatory affairs from San Diego State University.
Mr. Rushing is a well-known expert in the field of pharmaceutical quality validation and cGMP compliance and has worked with several leading companies in the industry. He will bring valuable insights and expertise to SOHM as the company works to diversify its portfolio with new products and expand to new markets. SOHM is confident that Mr. Rushing will help achieve its vision of becoming a global leader in healthcare solutions.
Mr. Dewey says he is thrilled to work with the management and leadership of SOHM. He enjoyed his role as a member of the Advisory Board and is eager to take the company to new heights in the coming months and years.
About SOHM, Inc.
SOHM, Inc. is a growing generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that aims to build continuous growth. SOHM manufacturing and marketing targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India and strategic alliances with U.S. manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America and Southeast Asia.
To learn more about SOHM, Inc., visit www.SOHM.com.
Safe Harbor Statement:
This news release contains “forward-looking statements,” which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
For more information, please contact:
SOHM, Inc.
714-522-6700
Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
Thank you, well thought out, and could very well play out that way. Hearing from WTER on 1Q, and growth/expansion updates will be nice going forward. We're about a week away from the HIRU Tweet "closing out another amazing quarter." imo. Gin n tonics. :)
hL
I was looking at a 24 hr chart, and was a bit off with my closing price % yesterday, might need to clean my glasses. (It was up nice from the LOD) Point being I guess, is it was a nice bounce from that low of .31 to .49. Today is still green so far. Very valid points QT on A88, thanks for posting them. hL
WTER bounced from .31 to .49, then closed yesterday .38 ish. Up 8% today. Might be showing signs of reversal but will depend probably on when they file the 1Q 2023. That RSI yesterday of 10 was insane. Traders took advantage of oversold.
__
imo. hL
(EDIT) Dr. AGuilar is still Full-Time at PMS:
Although he just recently changed his profile to put COO at SOHM at the top of his listing.
So he'll get Full-Time pay at PMS, and some sort of compensation at SOHM.
https://www.linkedin.com/in/david-aguilar-ph-d-51b8003a/
(Love LinkedIn)
...and just like Baron apparently, his compensation may show up in the "General and Administrative" itemization in the filings.
Although it won't likely show exactly what he is being salaried...based on their past. imo.
But we may not see any of that until the 3Q is due on NOV 15th. Might not even see any of who the New 25M Restricted went to, or who currently owns the 51 Pref A shares, or the Newly Issued Pref A shares, for new funding...til NOV 15 approx.
"Examples of general and administrative (G&A) expenses include building rent, consultant fees, depreciation on office furniture and equipment, insurance, supplies, subscriptions, and utilities. Salary and benefits attributable to certain employees, such as corporate management as well as the legal, accounting, and information technology (IT) departments are also classified as G&A expenses."
https://www.investopedia.com/terms/g/general-and-administrative-expenses.asp
---
imo. hL
$12,681,584 (6) Months Revs so far 2023:
9 Million Quarter coming for 3Q?
Historical:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172589013
___
hL hiru
High five for the use of "jalopy."
Respects. hL
Well said as always. Thank you. HL
WTER "The Company is working to satisfy the Nasdaq's requirements in a timely manner. The Company filed its Form 10-K on EDGAR on August 17, 2023. Filing the delinquent Form 10-Q would satisfy this obligation, however, there can be no assurance that the Company will regain compliance with the Rule or maintain the listing of its common stock on the Nasdaq. The Company wishes to reassure its stakeholders that it remains committed to fulfilling all requirements set forth by the Nasdaq and will leverage all available resources within its means to maintain its listing. If the Company's common stock ceases to be listed for trading on The Nasdaq Capital Market, the Company would expect that its common stock would be traded on one of the three tiered marketplaces of the OTC Markets Group."
https://www.otcmarkets.com/filing/html?id=16901336&guid=2Tg-kathMOxHJth
hL
Here's the Loopnet listing you referenced. The diagram is helpful in showing what part of the 8250-8292 address is for lease. Thanks for mentioning cabocat.
https://www.loopnet.com/Listing/8250-8292-Industrial-Ave-Roseville-CA/29301447/
hL
Really Cal Cal, what quick answers were gotten to your question?
Were you really hoping to get some insight Cal Cal?
Is that what you were hoping for?
Maybe on your 4th post you could bring answers instead of questions?
__
hL
You tell us Cal Cal. It's a big building, and Denman only has part of it. What are you trying to tell us? Last time you showed up it was to tell us about the lawsuit. What is it now? Facts only please.
hL